Loading…
Julian Naya Beauty LLC was cited for selling six unapproved injectable lipolytic (fat-dissolving) drug products—Kabelline, Lipo Lab PPC Solution, Lipo Lab V-Line, LemonBottle Ampoule Solution, Lipo Vela, and Neobella—through its website and social media channels in violation of sections 505(a) and 301(d) of the Federal Food, Drug, and Cosmetic Act. The company failed to obtain FDA approval before introducing these injectable drugs into interstate commerce, despite making disease treatment and body-structure-altering claims on its marketing materials. The FDA emphasized that injectable products pose heightened public health risks because they bypass the body's natural defenses and can directly enter the bloodstream, potentially causing serious or life-threatening harm.